Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma - Takeaways - MDSpire

Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma

  • By

  • Alessa Fischer

  • Hanna Remde

  • Christina Pamporaki

  • Ulrich Dischinger

  • Nicole Bechmann

  • Mercedes Robledo

  • Katharina Wang

  • Diana Vetter

  • José Oberholzer

  • Grégoire B Morand

  • Simon Andreas Mueller

  • Alexander Huber

  • Ralph Fritsch

  • Sven Gruber

  • Constanze Hantel

  • Kathrin Zitzmann

  • Martin Reincke

  • Christoph J Auernhammer

  • Karel Pacak

  • Ashley B Grossman

  • Felix Beuschlein

  • Svenja Nölting

  • January 2, 2025

  • 0 min

Share

  • 1

    Pheochromocytomas and paragangliomas are rare tumors that produce catecholamines, leading to significant cardiometabolic complications.

  • 2

    Patients with a history of resected PPGL show a higher prevalence of hyperglycemic disorders compared to asymptomatic pathogenic variant carriers.

  • 3

    Long-term follow-up of patients with resected PPGL reveals persistently elevated HbA1c levels compared to controls with nonfunctioning adrenal adenomas.

  • 4

    Cardiometabolic risk factors, including glycemic status, remain elevated in patients post-surgery, indicating the need for ongoing monitoring.

  • 5

    The study highlights the importance of specialized cardiometabolic follow-up for patients with a history of PPGL after tumor resection.

Original Source(s)

Related Content